 | Up a level |
2021
Griesinger, Frank, Eberhardt, Wilfried, Nusch, Arnd, Reiser, Marcel, Zahn, Mark-Oliver, Maintz, Christoph, Bernhardt, Christiane, Losem, Christoph, Stenzinger, Albrecht, Heukamp, Lukas C., Buettner, Reinhard, Marschner, Norbert, Jaenicke, Martina, Fleitz, Annette, Spring, Lisa, Sahlmann, Joerg, Karatas, Aysun, Hipper, Annette, Weichert, Wilko, Heilmann, Monika, Sadjadian, Parvis, Gleiber, Wolfgang, Grah, Christian, Waller, Cornelius F., Reck, Martin, Rittmeyer, Achim 
ORCID: 0000-0002-5280-6052, Christopoulos, Petros ORCID: 0000-0002-7966-8980, Sebastian, Martin and Thomas, Michael
(2021).
Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315).
Lung Cancer, 152.
S. 174 - 185.
CLARE:
ELSEVIER IRELAND LTD.
ISSN 1872-8332
Griesinger, Frank, Eberhardt, Wilfried, Nusch, Arnd, Reiser, Marcel, Zahn, Mark-Oliver, Maintz, Christoph, Bernhardt, Christiane, Losem, Christoph, Stenzinger, Albrecht, Heukamp, Lukas C., Buettner, Reinhard, Marschner, Norbert, Jaenicke, Martina, Fleitz, Annette, Spring, Lisa, Sahlmann, Joerg, Karatas, Aysun, Hipper, Annette, Weichert, Wilko, Heilmann, Monika, Sadjadian, Parvis, Gleiber, Wolfgang, Grah, Christian, Waller, Cornelius F., Reck, Martin, Rittmeyer, Achim, Christopoulos, Petros ORCID: 0000-0002-7966-8980, Sebastian, Martin and Thomas, Michael
(2021).
Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP registry (AIO-TRK-0315) (vol 152, pg 174, 2021).
Lung Cancer, 157.
S. 167 - 168.
CLARE:
ELSEVIER IRELAND LTD.
ISSN 1872-8332
2014
Nogova, Lucia, Gardizi, Masyar, Christiaan, Marc, Bos, Allardt, Scheffler, Matthias, Mattonet, Christian, Heukamp, Lukas Carl, Schildhaus, Hans-Ulrich, Fuhr, Uwe, Eberhardt, Wilfried, Reis, Henning, Wiesweg, Marcel, Schmid, Kurt Werner, Schoch, Gernot, Ko, Yon-Dschun, Serke, Monika Heidi, Schuler, Martin H., Buettner, Reinhard and Wolf, Juergen (2014). TRY: A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation. J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755